Page last updated: 2024-08-21

cyclopentane and Adenocarcinoma, Clear Cell

cyclopentane has been researched along with Adenocarcinoma, Clear Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ashworth, A; Dexter, T; El-Bahrawy, M; Faratian, D; Fenwick, K; Gabra, H; Gao, Q; Geyer, FC; Gore, ME; Graham, A; Jameson, C; Kaye, SB; Lambros, MB; Lord, CJ; Mackay, A; MarchiĆ², C; McCluggage, WG; Natrajan, R; Paige, AJ; Parry, S; Rayter, S; Reis-Filho, JS; Savage, K; Tamber, N; Tan, DS; Vatcheva, R; Williams, A; Zvelebil, M1

Other Studies

1 other study(ies) available for cyclopentane and Adenocarcinoma, Clear Cell

ArticleYear
PPM1D is a potential therapeutic target in ovarian clear cell carcinomas.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Apr-01, Volume: 15, Issue:7

    Topics: Adenocarcinoma, Clear Cell; Cell Line, Tumor; Chromosome Aberrations; Chromosomes, Human, Pair 17; Comparative Genomic Hybridization; Cyclopentanes; Enzyme Inhibitors; Female; Gene Amplification; Gene Expression Profiling; Genes, p53; Humans; Mutation; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphoprotein Phosphatases; Protein Phosphatase 2C; RNA Interference; Thiophenes

2009